International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. [Read more…] about Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia
A new study shows that severe cases of the coronavirus can cause strokes and other neurological issues, or an “altered mental state” for patients.
The research, published in the British medical journal Lancet Psychiatry, looked at a small pool of severe COVID-19 cases. The researchers found more than 100 patients who had either neurological or psychiatric problems from the coronavirus.
Epigenetic Changes Guide Development of Different Brain Regions (Dana Foundation):
“It’s one of the greatest standing mysteries in neuroscience: Given that each cell in the human body contains the same DNA, how, exactly, does the brain develop into distinct functional regions, supported by different cell types? And how might that developmental program go awry, resulting in neurodevelopmental disorders like schizophrenia or autism? The answers may be the epigenome [Read more…] about Epigenetics research opens potential door to prevent neurodevelopmental disorders
Psychedelics in Neurology: Potential for Improving Neuroplasticity (NeurologyTimes):
“Back in the 1950s, research was proving that psychedelic agents could be effective in the treatment of various neuropsychiatric disorders. Unfortunately, just as science was exploring their beneficial effects, the counterculture was exploring and embracing their effects. Slowly but surely, psychedelics were associated with rebellious youth and the tumultuous anti-war movement. As a result, the government shut down most of the research.
The 1990s saw renewed interest in psychedelic compounds as a means to address neuropsychiatric disorders. Research explored the benefits of MDMA and ketamine to treat mood disorders and posttraumatic stress disorder. Now, a new study sheds even more light on the promise these agents might provide. [Read more…] about Study: Psychedelics can promote neural plasticity in the prefrontal cortex and expand pathways for mental health
Tech Watches You for Digital Symptoms of Brain Disorders (IEEE Spectrum):
The medical professionals tasked with caring for our minds don’t have an easy job. To diagnose people with neuropsychiatric diseases, doctors can perform brain scans, but such scans are expensive and the results are sometimes inscrutable. The other options include conducting time-consuming cognitive tests, or relying on doctors’ own subjective analyses.
Seeing an opportunity, a number of startups have devised quantitative methods to diagnose diseases or assess mental health while patients complete routine activities, like talking on a smartphone, typing on a keyboard, or scrolling through a website. Here are three companies that say they can lift the “fingerprints” of mental disorders from people’s mundane behaviors.
Continue reading article to get a good update on Mindstrong Health, NeuraMetrix and WinterLight Labs. [Read more…] about Coming soon: Assessing your mental health while you talk on a phone, type on a keyboard, or scroll through a website
“Well into our 70s, we continue to develop new cells in an area of the brain responsible for new memories and exploration of new environments, scientists report.
“These new brain cells sustain our abilities to make new memories, learn, and cope with the environment, and they are important for [Read more…] about Study finds continued birth of new neurons (neurogenesis) well into our 70s